GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » 14-Day RSI

Veradigm (Veradigm) 14-Day RSI : 53.71 (As of Apr. 27, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Veradigm 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-04-27), Veradigm's 14-Day RSI is 53.71.

The industry rank for Veradigm's 14-Day RSI or its related term are showing as below:

MDRX's 14-Day RSI is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 45.28 vs MDRX: 53.71

Competitive Comparison of Veradigm's 14-Day RSI

For the Health Information Services subindustry, Veradigm's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veradigm's 14-Day RSI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Veradigm's 14-Day RSI falls into.



Veradigm  (OTCPK:MDRX) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Veradigm  (OTCPK:MDRX) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Veradigm 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Veradigm's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Veradigm (Veradigm) Business Description

Traded in Other Exchanges
N/A
Address
222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654
Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.
Executives
Shih Yin Ho director 222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez director C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton officer: CFO 3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia officer: SVP Gerneral Counsel 222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens director 1 IMATION WAY, OAKDALE MN 55128
Leah Jones officer: Chief Financial Officer 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black director 400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman director 10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan officer: President and CCO 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond officer: SVP & Chief HR Officer 305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison director 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey officer: Chief Client Delivery Officer 222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko director
Carol J Zierhoffer director 100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley officer: SVP Gerneral Counsel & Corpora 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654

Veradigm (Veradigm) Headlines

From GuruFocus